| Document Date: 2012-01-30 16:15:55
Open Document File Size: 470,83 KBShare Result on Facebook
City Approved Reference / / IndustryTerm treatment of HIV / food / treatment of neoplastic diseases / / MedicalCondition polycythemia vera / thrombocythemia / secondary leukemias / leukemia / priapism / HIV / thrombocythemia / tumors / disease / Hyperpigmentation / leukopenia / Carcinogenesis / sickle cell anemia / dysfunction / Skin cancer / ESRD / Neutropenia / myeloproliferative disorders / nausea / skin rash / stomatitis / Thrombocytopenia / erythema / fever / Peripheral neuropathy / vomiting / hepatic failure / diseases / pancreatitis / patient’s underlying disease / sickle cell disease / hydrocephaly / hypersensitivity / diarrhea / infection / end-stage renal disease / constipation / folic acid deficiency / rash / anemia / syndrome / disorders / / MedicalTreatment hemodialysis / dialysis / blood transfusions / / Position physician / General / / Product hydroxyurea / DROXIA / folic acid / didanosine / stavudine / / Technology Pharmacokinetics / DNA synthesis / dialysis / /
SocialTag |
Rx only DROXIA® (hydroxyurea capsules, USP) WARNING Treatment of patients with DROXIA may be complicated by severe, sometimes lifethreatening, adverse effects. DROXIA should be administered under the supervision of a